Clinical Trials Logo

Filter by:
NCT ID: NCT02884492 Terminated - Alzheimer's Disease Clinical Trials

Imaging Tau in Alzheimer's Disease and Normal Aging

Start date: July 2016
Phase: Phase 2
Study type: Interventional

This study is being done to learn about tau tangles in Alzheimer's disease. A type of PET scan is used to measure the abnormal accumulation of protein called tau in the brain. These are thought to be involved in Alzheimer's disease. The investigators will also perform brain MRI and to tests to measure the participant's memory and thinking.

NCT ID: NCT02883426 Terminated - Influenza Clinical Trials

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

Start date: September 2016
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety and immunogenicity of the H3N2v MN 2010/AA ca live attenuated influenza vaccine (H3N2v LAIV) in healthy children and adults, 6 to 26 years old.

NCT ID: NCT02882841 Terminated - Crohn's Disease Clinical Trials

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients

MOBIDIC
Start date: September 2016
Phase: N/A
Study type: Interventional

The study is a multicenter, international descriptive study with a bio-collection in 300 evaluable Crohn's disease patients to be processed after usual biological tests via bioinformatics tools. At this time, this study has no impact neither on treatment nor on disease diagnostic, these will be based on usual medical practices and is no investigational product associated with the conduct of this study.

NCT ID: NCT02882711 Terminated - Clinical trials for Major Depressive Disorder

The UTHealth Ketamine Project

Start date: November 7, 2016
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine the effectiveness of serial infusions of intravenous (IV) ketamine in adults with treatment resistant depression (TRD).

NCT ID: NCT02882321 Terminated - Clinical trials for Refractory Acute Myeloid Leukemia

Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Start date: September 29, 2016
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of oxidative phosphorylation inhibitor IACS-010759 in treating patients with acute myeloid leukemia that has come back or does not respond to treatment. Oxidative phosphorylation inhibitor IACS-010759 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT02882048 Terminated - Narcotic Addiction Clinical Trials

Auricular Acupuncture to Facilitate Outpatient Opioid Weaning

Start date: September 2016
Phase: N/A
Study type: Interventional

This study is to compare two groups undergoing opioid weaning as ordered by their referring physicians. One group will undergo the standard opioid weaning process and the other group will have the addition of the NADA Protocol to the weaning process.

NCT ID: NCT02881567 Terminated - Clinical trials for Relapsing-Remitting Multiple Sclerosis (RRMS)

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

SUSTAIN
Start date: April 18, 2017
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to evaluate the effects of treatment with daclizumab on the proportion of participants relapse-free at 6 months in Relapsing-Remitting Multiple Sclerosis (RRMS) participants, who switched from treatment with natalizumab to daclizumab due to safety concerns. The secondary objectives of this study in this study population are to evaluate the effects of daclizumab on the following: 1) Multiple Sclerosis (MS) relapse activity including the annualized relapse rate (ARR) and the proportion of participants experiencing relapses requiring hospitalization and/or steroid treatment; 2) MS-related outcomes measured using magnetic resonance imaging (MRI); 3) Safety and tolerability in participants previously treated with natalizumab.

NCT ID: NCT02881229 Terminated - Vulvodynia Clinical Trials

Vulvar Mucosal Specialty Clinic Chart Review

Start date: April 2016
Phase:
Study type: Observational

This study aims to develop a clinical database of patients presenting with vulvar complaints in order to comprehensively assess the presentation and current trends in management of vulvar disease.

NCT ID: NCT02881047 Terminated - Clinical trials for Subjects With Severe, Refractory Sclerotic Skin Changes

Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures

Start date: November 11, 2013
Phase: N/A
Study type: Interventional

Graft versus host disease (GVHD) is a common complication of allogeneic stem cell transplant.Chronic GVHD is characterized by skin thickening and tightening. Advanced sclerosis can lead to reduced range of motion and incapacitating joint contractures. Once present, there are few therapeutic options. We will treat sclerosis and limb contractures with an ablative fractional laser, a device FDA-approved for scar treatment. This approach has successfully treated contracturesdue to burn scars.

NCT ID: NCT02880904 Terminated - Lichen Sclerosus Clinical Trials

Vulvar Scarring Grading Scale for Lichen Sclerosus

Start date: March 2016
Phase:
Study type: Observational

The study aims to validate a vulvar scarring grading scale for lichen sclerosus (LS).